InPharm - Research and Development News
Company will make further cuts to its staff after a turbulent year
Will join custom manufacturing and services business unit of Sigma-Aldrich
Will gain rights to potential blood cancer treatment blinatumomab
Tufts CSDD survey also shows US and non-US differences
Visiongain report predicts growth in products and services








